CD133 + cells as a therapeutic target for kidney diseases

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 2, 2012, Pages 157-165

  Bussolati, Benedetta ^a   Collino, Federica ^a   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

AC133 targeting; Cancer stem cells; Crescents; Hypoxia; Polycystic kidney disease; Progenitor cells; Renal; Repair

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CD133 ANTIBODY; CD133 ANTIBODY MONOMETHYL AURISTATIN F CONJUGATE; CD133 ANTIGEN; CD133 SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY PLUS PE38KDEL TOXIN; CD133 SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY PLUS PSEUDOMONAS EXOTOXIN A VARIANT; CD133 STEM CELL VACCINE; IMMUNOTOXIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MARKER; GLOMERULOPATHY; GLYCOLYSIS; HUMAN; KIDNEY CARCINOMA; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY REPAIR; LIVER CELL CARCINOMA; MYELOID LEUKEMIA; NEPHRON; NONHUMAN; PHENOTYPE; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REVIEW; STEM CELL; TISSUE REGENERATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; GLYCOPROTEINS; HUMANS; KIDNEY DISEASES; PEPTIDES;

EID: 84857429563     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.661417     Document Type: Review

References (64)

1. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12
2. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21
3. Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytypic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 1997;94:12425-30
4. Fargeas CA, Florek M, Huttner WB, Corbeil D. Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem 2003;278:8586-96
5. Corbeil D, Roper K, Fargeas CA, et al. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2001;2:82-91
6. Fargeas CA, Corbeil D, Huttner WB. AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells 2003;21:506-8
7. Fargeas CA, Huttner WB, Corbeil D. Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antigens 2007;69:602-6
8. Corbeil D, Roper K, Weigmann A, Huttner WB. AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood 1998;91:2625-6
9. Miraglia S, Godfrey W, Buck D. A response to AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood 1998;91:4390-1
10. Potgens AJ, Schmitz U, Kaufmann P, Frank HG. Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18. J Histochem Cytochem 2002;50:1131-4
11. Corbeil D, Roper K, Hellwig A, et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000;275:5512-20
12. Florek M, Haase M, Marzesco AM, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005;319:15-26
13. Shmelkov SV, Jun L, St Clair R, et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 2004;103:2055-61
14. Angelotti ML, Lazzeri E, Lasagni L, Romagnani P. Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors. Kidney Int 2010;78:620-1
15. Immervoll H, Hoem D, Sakariassen PO, et al. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 2008;8:48
16. Lardon J, Corbeil D, Huttner WB, et al. Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas 2008;36:e1-6
17. Karbanova J, Missol-Kolka E, Fonseca AV, et al. The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 2008;56:977-93
18. Kemper K, Sprick MR, de Bree M, et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 2010;70:719-29
19. Mak AB, Blakely KM, Williams RA, et al. CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem 2011;286:41046-56
20. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008;86:1025-32
21. Richardson GD, Robson CN, Lang SH, et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004;117:3539-45
22. Samuel S, Walsh R, Webb J, et al. Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts. Am J Physiol Cell Physiol 2009;296:C296-305
23. Germano D, Blyszczuk P, Valaperti A, et al. Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:939-49
24. Zhao M, Amiel SA, Christie MR, et al. Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J Endocrinol 2007;195:407-14
25. Coskun V, Wu H, Blanchi B, et al. CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci USA 2008;105:1026-31
26. Bussolati B, Bruno S, Grange C, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005;166:545-55
27. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006;17:2443-56
28. Sallustio F, De Benedictis L, Castellano G, et al. TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J 2010;24:514-25
29. Bussolati B, Moggio A, Collino F, et al. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol 2012;302:F116-28
30. Ward HH, Romero E, Welford A, et al. Adult human CD133/1(+) kidney cells isolated from papilla integrate into developing kidney tubules. Biochim Biophys Acta 2011;1812:1344-57
31. Humphreys BD, Valerius MT, Kobayashi A, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008;6:284-91
32. Humphreys BD, Czerniak S, DiRocco DP, et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA 2011;108:9226-31
33. Xu N, Papagiannakopoulos T, Pan G, et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009;137:647-58
34. Loverre A, Capobianco C, Ditonno P, et al. Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function. Transplantation 2008;85:1112-19
35. Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009;20:322-32
36. Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009;20:333-43
37. Smeets B, Angelotti ML, Rizzo P, et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009;20:2593-603
38. Carvalhosa R, Deambrosis I, Carrera P, et al. Cystogenic potential of CD133+ progenitor cells of human polycystic kidneys. J Pathol 2011;225:129-41
39. Calvet JP. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation? Kidney Int 1993;43:101-8
40. Harris PC. What is the role of somatic mutation in autosomal dominant polycystic kidney disease? J Am Soc Nephrol 2010;21:1073-6
41. Patel V, Li L, Cobo-Stark P, et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet 2008;17:1578-90
42. Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell 2006;124:1111-15
43. Sell S. On the stem cell origin of cancer. Am J Pathol 2010;176:2584-94
44. Ferrandina G, Petrillo M, Bonanno G, Scambia G. Targeting CD133 antigen in cancer. Expert Opin Ther Targets 2009;13:823-37
45. Bruno S, Bussolati B, Grange C, et al. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 2006;169:2223-35
46. Bussolati B, Bruno S, Grange C, et al. Identification of a tumor-initiating stem cell population in human renal carcinomas. Faseb J 2008;22:3696-705
47. Addla S, Brown M, Hart C, et al. Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells. Am J Physiol Renal Physiol 2008;295:F680-7
48. Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-806
49. D'Alterio C, Cindolo L, Polimeno M, et al. Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle 2010;9:4492-500
50. da Costa WH, Rocha RM, da Cunha IW, et al. CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma. World J Urol 2011; [Epub ahead of print]
51. Lindgren D, Bostrom AK, Nilsson K, et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 2011;178:828-37
52. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000;2:582-92
53. Fargeas CA, Karbanova J, Jaszai J, et al. CD133 and membrane microdomains: old facets for future hypotheses. World J Gastroenterol 2011;17:4149-52
54. Ding Q, Yoshimitsu M, Kuwahata T, et al. Establishment of a highly migratory sub clone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer. Hum Cell 2011; [Epub ahead of print]
55. Smith LM, Nesterova A, Ryan MC, et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 2008;99:100-9
56. Schwemmlein M, Peipp M, Barbin K, et al. A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells. Br J Haematol 2006;133:141-51
57. Waldron NN, Kaufman DS, Oh S, et al. Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer. Mol Cancer Ther 2011;10:1829-38
58. Mitchell D; Principal Investigator. Available from: www.clinicaltrials. gov identification number: NCT00890032
59. Bourseau-Guilmain E, Griveau A, Benoit JP, Garcion E. The importance of the stem cell marker prominin-1/ CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS ONE 2011;6:e25515
60. Yang C, Yang Y, Gupta N, et al. Pentaspan membrane glycoprotein, prominin-1, is involved in glucose metabolism and cytoskeleton alteration. Biochemistry 2007;72:854-62
61. Griguer CE, Oliva CR, Gobin E, et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS One 2008;3:e3655
62. Warburg O. On respiratory impairment in cancer cells. Science 1956;124:269-70
63. Soeda A, Park M, Lee D, et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009;28:3949-59
64. Pistollato F, Chen HL, Schwartz PH, et al. Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 2007;35:424-35